Moderna Covid-19 Vaccine: Here Is The Risk Of Severe Allergic Reactions
A new CDC reported listed the rate of anaphylaxis after the Moderna Covid-19 mRNA as slightly lower than that of the Pfizer/BioNTech vaccine. But is this difference real? (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - January 23, 2021 Category: Pharmaceuticals Authors: Bruce Y. Lee, Senior Contributor Tags: Healthcare /healthcare Innovation /innovation Science /science business pharma Source Type: news

Covid US: 10 out of 4m who got Moderna vaccine suffered anaphylaxis
Just one person who went into anaphylactic shock - a life-threatening response in which a person's airways can become too narrow for them to breathe - had no history of allergies, CDC reports. (Source: the Mail online | Health)
Source: the Mail online | Health - January 23, 2021 Category: Consumer Health News Source Type: news

10 out of 4 million Americans to get Moderna's vaccine suffered anaphylaxis
Just one person who went into anaphylactic shock - a life-threatening response in which a person's airways can become too narrow for them to breathe - had no history of allergies, CDC reports. (Source: the Mail online | Health)
Source: the Mail online | Health - January 22, 2021 Category: Consumer Health News Source Type: news

Allergic reactions including anaphylaxis after receipt of 1st dose of Pfizer-BioNTech COVID-19 Vaccine
(JAMA Network) This JAMA Insights review provides clinical details of anaphylactic reactions reported to and verified by the Centers for Disease Control and Prevention in the first week of use of the Pfizer-BioNTech COVID-19 vaccine in the United States. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - January 21, 2021 Category: International Medicine & Public Health Source Type: news

How Safe Are Covid-19 Coronavirus Vaccines? Here ’s The Allergic Reaction Risk
A CDC report indicated that there were 21 cases of anaphylaxis (severe allergic reactions) out of 1,893,360 people who had received first doses of the Pfizer-BioNTech Covid-19 vaccine. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - January 16, 2021 Category: Pharmaceuticals Authors: Bruce Y. Lee, Senior Contributor Tags: Healthcare /healthcare Innovation /innovation Science /science business pharma Source Type: news

DARZALEX FASPRO ® (daratumumab and hyaluronidase-fihj) Becomes the First FDA-Approved Treatment for Patients with Newly Diagnosed Light Chain (AL) Amyloidosis
January 15, 2021 (HORSHAM, Pa.) – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today the U.S. Food and Drug Administration (FDA) approval of DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj), a subcutaneous formulation of daratumumab, in combination with bortezomib, cyclophosphamide and dexamethasone (D-VCd) for the treatment of adult patients with newly diagnosed light chain (AL) amyloidosis.[1] DARZALEX FASPRO® is the first and only FDA-approved treatment for patients with this blood cell disorder that is associated with the production of an abnormal protein, which leads to th...
Source: Johnson and Johnson - January 16, 2021 Category: Pharmaceuticals Tags: Our Company Source Type: news

COVID-19 vaccination programme, RCGP (updated 14th January 2021)
The latest updates on the COVID-19 vaccine, including: COVID-19 Vaccination FAQs SARS-CoV-2 Vaccination #RCGPLive: COVID-19 vaccination in general practice Managing anaphylaxis: guidance for GPs delivering the COVID-19 vaccine (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - January 15, 2021 Category: Consumer Health News Source Type: news

In lab study, nanoparticle shows promising results for treating severe allergies
For about 1 in 13 children in the U.S., usually harmless foodstuffs such as milk, eggs and peanuts can send the body ’s natural defenses into overdrive.Symptoms of food allergies can vary widely, but at worst, a systemwide allergic response can lead to anaphylaxis, a life-threatening condition characterized by a sudden drop in blood pressure and difficulty breathing.Although there are now some preventive measures for food-induced anaphylaxis, there are not yet any long-lasting solutions — treatments capable of locking the immune system into a state of tolerance, so that it doesn’t respond to allergens.Now...
Source: UCLA Newsroom: Health Sciences - January 14, 2021 Category: Universities & Medical Training Source Type: news

Update on COVID-19 pandemic, BMJ Best Practice (updated 8th January 2021)
Over 88 million cases have been reported globally, with over 49 million cases recovered so far, and approximately 1.9 million deaths according to data compiled by the Center for Systems Science and Engineering at Johns Hopkins University. What's new at this update: Epidemiology: updated data on children and pregnant women; updated risk factors (residence in a long-term care facility; cardiovascular diseases; diabetes; chronic respiratory diseases). Aetiology: new section on SARS-CoV-2 variants; updated data on secondary attack rates. Investigations: WHO recommends PCR test results are considered in combinatio...
Source: Current Awareness Service for Health (CASH) - January 11, 2021 Category: Consumer Health News Source Type: news

Allergic reactions including anaphylaxis after receipt of the first dose of Pfizer-BioNTech COVID-19 vaccine United States, December 14-23, 2020, Morbidity and Mortality Weekly Report
During 14 –23 Dec 2020, there were 21 reports of anaphylaxis after administration of 1,893,360 first doses of the Pfizer-BioNTech COVID-19 vaccine (11.1 cases per million doses) made to the Vaccine Adverse Event Reporting System; 71% occurred within 15 minutes of vaccination. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - January 11, 2021 Category: Consumer Health News Source Type: news

What Are the Signs of Anaphylaxis
? (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - January 11, 2021 Category: General Medicine Source Type: news

What Are the Two Signs of Anaphylaxis?
Title: What Are the Two Signs of Anaphylaxis?Category: Diseases and ConditionsCreated: 1/11/2021 12:00:00 AMLast Editorial Review: 1/11/2021 12:00:00 AM (Source: MedicineNet Allergies General)
Source: MedicineNet Allergies General - January 11, 2021 Category: Allergy & Immunology Source Type: news

11.1 Anaphylaxis Cases/Million Doses of Pfizer-BioNTech COVID-19 Vaccine Reported
THURSDAY, Jan. 7, 2021 -- As of Dec. 23, 2020, researchers determined there were 21 cases of anaphylaxis (11.1 per million doses administered) after receipt of the first dose of the Pfizer-BioNTech COVID-19 vaccine in the United States, according to... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 7, 2021 Category: Pharmaceuticals Source Type: news

Severe Allergic Reactions to COVID-19 Vaccine Are Rare: CDC
The majority of people experiencing anaphylaxis had a history of allergic reactions, a report by the agency finds. (Source: The Scientist)
Source: The Scientist - January 7, 2021 Category: Science Tags: News & Opinion Source Type: news

What You Need to Know About the Coronavirus Outbreak
That ’s a rate of 11.1 cases of anaphylaxis per 1 million recipients. ... Seventeen of the 21 who experienced anaphylaxis had a history of similar reactions to other vaccines or medications, the CDC... (Source: AARP.org News)
Source: AARP.org News - January 7, 2021 Category: American Health Source Type: news

What to Know About Allergic Reactions to COVID Vaccines
There have been a handful of anaphylaxis cases; be aware if you are at risk ... En espa ñol | Among 1.8 million people in the U.S. who've received the first dose of Pfizer-BioNTech or Moderna COVID-... (Source: AARP.org News)
Source: AARP.org News - January 7, 2021 Category: American Health Source Type: news

Anaphylaxis Cases After COVID Vaccine Rising But Still Rare: CDC Anaphylaxis Cases After COVID Vaccine Rising But Still Rare: CDC
With 29 confirmed cases of anaphylaxis following COVID-19 vaccine administration, clinicians should be prepared to treat this side effect, CDC's Messonnier said. But cases remain rare.Medscape Medical News (Source: Medscape Emergency Medicine Headlines)
Source: Medscape Emergency Medicine Headlines - January 6, 2021 Category: Emergency Medicine Tags: Allergy & Clinical Immunology News Source Type: news

Allergic Reactions to COVID Vaccines Are Rare, Resolved on Site: CDC
WEDNESDAY, Jan. 6, 2021 -- Cases of anaphylactic shock caused by COVID-19 vaccines are very rare, based on numbers from the first week and a half of vaccinations in the United States, federal public health officials said Wednesday. There have been... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - January 6, 2021 Category: General Medicine Source Type: news

At least 21 Americans had life-threatening anaphylaxis after receiving Pfizer's vaccine, CDC reveals
A new CDC report revealed 21 people out of 1.9 million suffered anaphylaxis after getting the first dose of Pfizer-BioNTech's coronavirus vaccine between December 14 and 23. (Source: the Mail online | Health)
Source: the Mail online | Health - January 6, 2021 Category: Consumer Health News Source Type: news

Essential guidance, RCGP (updated 6th January 2021)
This guidance provides key information for GPs during the COVID-19 outbreak and includes, amongst other things, sections on: Managing anaphylaxis: guidance for GPs delivering the COVID-19 vaccine SARS-CoV-2 Vaccination. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - January 6, 2021 Category: Consumer Health News Source Type: news

Patients with history of anaphylaxis can have Pfizer COVID jab, says MHRA
Patients with a history of severe allergy are now able to have the Pfizer/BioNTech COVID-19 vaccine, the MHRA has said. (Source: GP Online News)
Source: GP Online News - January 6, 2021 Category: Primary Care Tags: Coronavirus Source Type: news

Maintaining Safety with SARS-CoV-2 Vaccines, New England Journal of Medicine
Viewpoint article comments on the expedited recent approval of these vaccines and reports of anaphylaxis with the Pfizer vaccine and concludes careful vaccine-safety surveillance over time will be needed to inform a strategic and systematic approach to vaccine safety. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - January 5, 2021 Category: Consumer Health News Source Type: news

Too Many Americans Still Mistrust the COVID-19 Vaccines. Here ’s Why
If you’re feeling impatient waiting your turn for a COVID-19 vaccine, here’s a little good news: Angela Padgett will gladly give you her place in line—at least for now. Padgett, president of a day spa in Raleigh, N.C., is under no illusions about the mortal danger the pandemic poses to herself, her family and the world writ large—indeed, she had COVID-19 back in July. But as for the vaccine that is supposed to put an end to all of the suffering at last? Not today. “I am a little bit hesitant,” she says. “I can appreciate President Trump trying to get this moving fast and I’ve...
Source: TIME: Health - January 5, 2021 Category: Consumer Health News Authors: Jeffrey Kluger Tags: Uncategorized COVID-19 Source Type: news

Essential guidance, RCGP (updated 30th December 2020)
This guidance provides key information for GPs during the COVID-19 outbreak and includes, amongst other things, sections on: Managing anaphylaxis: guidance for GPs delivering the COVID-19 vaccine SARS-CoV-2 Vaccination. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - January 4, 2021 Category: Consumer Health News Source Type: news

Allergists offer reassurance regarding potential allergic reactions to COVID-19 vaccines
(Massachusetts General Hospital) Reports of possible allergic reactions to COVID-19 vaccines have raised public concern; however, allergists note that allergic reactions to vaccines are rare, and COVID-19 vaccine allergic reactions will have a similarly low rate of occurrence. Individuals with a history of anaphylaxis to an injectable drug or vaccine containing polyethylene glycol or polysorbate should speak with an allergist before getting vaccinated, but patients with severe allergies to foods, oral drugs, latex or venom can safely receive the COVID-19 vaccines. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - December 31, 2020 Category: International Medicine & Public Health Source Type: news

How Drive-Through COVID-19 Vaccine Clinics Could Help Inoculate the U.S.
Even though the COVID-19 vaccine clinic wasn’t due to open until 5 p.m., cars started lining up around about 15 minutes early, just as darkness, and some snowflakes, started to fall. The vehicles, some ambulances and other types of emergency response cars, belonged to 70 first responders in Minnesota’s Carlton County who wanted to be among the first in the area to get vaccinated against COVID-19. They drove through the large parking garage in Carlton, run by the county’s transportation department, where they received one of the northern Minnesota county’s allotment of 100 doses of the vaccine made b...
Source: TIME: Health - December 30, 2020 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized COVID-19 Source Type: news

Boston Doctor Develops Severe Allergic Reaction After Getting Moderna Vaccine
The patient, who has a severe shellfish allergy, recovered quickly with treatment. Until now, reports of severe reactions had been linked to the Pfizer vaccine. (Source: NYT Health)
Source: NYT Health - December 25, 2020 Category: Consumer Health News Authors: Katherine J. Wu Tags: Vaccination and Immunization Drugs (Pharmaceuticals) Anaphylactic Shock Coronavirus (2019-nCoV) Immune System Allergies Centers for Disease Control and Prevention Moderna Inc Pfizer Inc your-feed-healthcare Source Type: news

NIH Is Planning A Study To Find Out What ’s Causing Allergic Reactions To Pfizer’s Covid-19 Vaccine
The CDC is investigating six cases of anaphylaxis from the vaccine. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - December 21, 2020 Category: Pharmaceuticals Authors: Rachel Sandler, Forbes Staff Tags: Business /business Innovation /innovation Healthcare /healthcare Breaking breaking-news Source Type: news

FDA Panel Recommends Moderna ’s COVID-19 Vaccine, the Second To Receive Such Approval in the U.S.
In an overwhelming 20 to zero vote, with one abstention, the U.S. Food and Drug Administration’s vaccine advisory committee recommended that the agency authorize the second COVID-19 vaccine for emergency use in the country. The FDA will now decide whether or not to take the committee’s advice; last week, the agency did follow the committee’s lead in authorizing for emergency use the Pfizer-BioNTech vaccine on Dec. 11. This second vaccine, mRNA-1273, made by Massachusetts-based biotech Moderna, uses the same technology as the Pfizer-BioNTech vaccine and in trials showed similar efficacy in protecting again...
Source: TIME: Health - December 18, 2020 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized COVID-19 Source Type: news

Moderna ’s COVID-19 Vaccine Becomes Second Shot Authorized for Emergency Use in the U.S.
The U.S. now has two COVID-19 vaccines that are safe and effective enough for the public. On Dec. 18, the Food and Drug Administration issued an emergency use authorization (EUA) for a COVID-19 vaccine made by Moderna, a biotech company based in Massachusetts. The decision followed an overwhelming 20 to zero vote, with one abstention, in favor or authorizing the vaccine by an FDA vaccine advisory committee on Dec. 17. “This evening the FDA granted the second emergency use authorization for a COVID-19 vaccine,” Dr. Stephen Hahn, commissioner of the FDA, said during a media briefing announcing the decision. &ld...
Source: TIME: Health - December 18, 2020 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized COVID-19 Source Type: news

Essential guidance, RCGP (updated 18th December 2020)
Key information for GPs during the COVID-19 outbreak on: Coronavirus - Top 10 tips on what to do in primary care Paediatrics top tips: COVID-19 relating to children and young people Changes to death certification COVID-19: Myth busting Management of the long term effects of COVID-19 Managing anaphylaxis: guidance for GPs deliveri ng the COVID-19 vaccine. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - December 18, 2020 Category: Consumer Health News Source Type: news

Health Officials Track Safety as COVID-19 Vaccines Roll Out
By LAURAN NEERGAARD AP Medical Writer As COVID-19 vaccinations roll out to more and more people, health authorities are keeping close watch for any unexpected side effects. On Tuesday, a health worker in Alaska suffered a severe allergic reaction after receiving the Pfizer COVID-19 vaccine. She is in the hospital for another night under observation while another worker, vaccinated Wednesday, has recovered. Doctors already knew to be on the lookout after Britain reported two similar cases last week. Related: Emergency Considerations in COVID-19 Vaccine Administration In the U.S., vaccine recipients are supposed ...
Source: JEMS Patient Care - December 17, 2020 Category: Emergency Medicine Authors: JEMS Staff Tags: AP News Coronavirus Source Type: news

Health Officials Track Safety as COVID-19 Vaccines Roll Out
By LAURAN NEERGAARD AP Medical Writer As COVID-19 vaccinations roll out to more and more people, health authorities are keeping close watch for any unexpected side effects. On Tuesday, a health worker in Alaska suffered a severe allergic reaction after receiving the Pfizer COVID-19 vaccine. She is in the hospital for another night under observation while another worker, vaccinated Wednesday, has recovered. Doctors already knew to be on the lookout after Britain reported two similar cases last week. Related: Emergency Considerations in COVID-19 Vaccine Administration In the U.S., vaccine recipients are supposed ...
Source: JEMS Administration and Leadership - December 17, 2020 Category: Emergency Medicine Authors: JEMS Staff Tags: AP News Coronavirus Source Type: news

Health Officials Track Safety as COVID-19 Vaccines Roll Out
By LAURAN NEERGAARD AP Medical Writer As COVID-19 vaccinations roll out to more and more people, health authorities are keeping close watch for any unexpected side effects. On Tuesday, a health worker in Alaska suffered a severe allergic reaction after receiving the Pfizer COVID-19 vaccine. She is in the hospital for another night under observation while another worker, vaccinated Wednesday, has recovered. Doctors already knew to be on the lookout after Britain reported two similar cases last week. Related: Emergency Considerations in COVID-19 Vaccine Administration In the U.S., vaccine recipients are supposed ...
Source: JEMS Latest News - December 17, 2020 Category: Emergency Medicine Authors: JEMS Staff Tags: AP News Coronavirus Source Type: news

Health Officials Track Safety as COVID-19 Vaccines Roll Out
By LAURAN NEERGAARD AP Medical Writer As COVID-19 vaccinations roll out to more and more people, health authorities are keeping close watch for any unexpected side effects. On Tuesday, a health worker in Alaska suffered a severe allergic reaction after receiving the Pfizer COVID-19 vaccine. She is in the hospital for another night under observation while another worker, vaccinated Wednesday, has recovered. Doctors already knew to be on the lookout after Britain reported two similar cases last week. Related: Emergency Considerations in COVID-19 Vaccine Administration In the U.S., vaccine recipients are supposed ...
Source: JEMS: Journal of Emergency Medical Services News - December 17, 2020 Category: Emergency Medicine Authors: JEMS Staff Tags: AP News Coronavirus Source Type: news

Health Officials Track Safety as COVID-19 Vaccines Roll Out
By LAURAN NEERGAARD AP Medical Writer As COVID-19 vaccinations roll out to more and more people, health authorities are keeping close watch for any unexpected side effects. On Tuesday, a health worker in Alaska suffered a severe allergic reaction after receiving the Pfizer COVID-19 vaccine. She is in the hospital for another night under observation while another worker, vaccinated Wednesday, has recovered. Doctors already knew to be on the lookout after Britain reported two similar cases last week. Related: Emergency Considerations in COVID-19 Vaccine Administration In the U.S., vaccine recipients are supposed ...
Source: JEMS Operations - December 17, 2020 Category: Emergency Medicine Authors: JEMS Staff Tags: AP News Coronavirus Source Type: news

Health Officials Track Safety as COVID-19 Vaccines Roll Out
By LAURAN NEERGAARD AP Medical Writer As COVID-19 vaccinations roll out to more and more people, health authorities are keeping close watch for any unexpected side effects. On Tuesday, a health worker in Alaska suffered a severe allergic reaction after receiving the Pfizer COVID-19 vaccine. She is in the hospital for another night under observation while another worker, vaccinated Wednesday, has recovered. Doctors already knew to be on the lookout after Britain reported two similar cases last week. Related: Emergency Considerations in COVID-19 Vaccine Administration In the U.S., vaccine recipients are supposed ...
Source: JEMS Special Topics - December 17, 2020 Category: Emergency Medicine Authors: JEMS Staff Tags: AP News Coronavirus Source Type: news

Emergency Considerations in COVID-19 Vaccine Administration
Conclusion The joint response of science and medicine to develop safe and effective COVID-19 vaccines has been brisk and productive. Distribution efforts will now be the next step in limiting the breadth of this pandemic. EMS agencies will play a key role in some areas in the administration of vaccinations for their communities. The authors suggest that to better clarify the side effects of the COVID-19 vaccines, EMS systems must maintain a log of the type and incidence of adverse events following vaccine administration, EMS responses to the adverse events, as well as those patients’ outcomes from this manageme...
Source: JEMS Patient Care - December 16, 2020 Category: Emergency Medicine Authors: JEMS Staff Tags: Coronavirus Exclusives EMS EMT Paramedic Source Type: news

Emergency Considerations in COVID-19 Vaccine Administration
Conclusion The joint response of science and medicine to develop safe and effective COVID-19 vaccines has been brisk and productive. Distribution efforts will now be the next step in limiting the breadth of this pandemic. EMS agencies will play a key role in some areas in the administration of vaccinations for their communities. The authors suggest that to better clarify the side effects of the COVID-19 vaccines, EMS systems must maintain a log of the type and incidence of adverse events following vaccine administration, EMS responses to the adverse events, as well as those patients’ outcomes from this manageme...
Source: JEMS Administration and Leadership - December 16, 2020 Category: Emergency Medicine Authors: JEMS Staff Tags: Coronavirus Exclusives EMS EMT Paramedic Source Type: news

Emergency Considerations in COVID-19 Vaccine Administration
Conclusion The joint response of science and medicine to develop safe and effective COVID-19 vaccines has been brisk and productive. Distribution efforts will now be the next step in limiting the breadth of this pandemic. EMS agencies will play a key role in some areas in the administration of vaccinations for their communities. The authors suggest that to better clarify the side effects of the COVID-19 vaccines, EMS systems must maintain a log of the type and incidence of adverse events following vaccine administration, EMS responses to the adverse events, as well as those patients’ outcomes from this manageme...
Source: JEMS Latest News - December 16, 2020 Category: Emergency Medicine Authors: JEMS Staff Tags: Coronavirus Exclusives EMS EMT Paramedic Source Type: news

Emergency Considerations in COVID-19 Vaccine Administration
Conclusion The joint response of science and medicine to develop safe and effective COVID-19 vaccines has been brisk and productive. Distribution efforts will now be the next step in limiting the breadth of this pandemic. EMS agencies will play a key role in some areas in the administration of vaccinations for their communities. The authors suggest that to better clarify the side effects of the COVID-19 vaccines, EMS systems must maintain a log of the type and incidence of adverse events following vaccine administration, EMS responses to the adverse events, as well as those patients’ outcomes from this manageme...
Source: JEMS: Journal of Emergency Medical Services News - December 16, 2020 Category: Emergency Medicine Authors: JEMS Staff Tags: Coronavirus Exclusives EMS EMT Paramedic Source Type: news

Emergency Considerations in COVID-19 Vaccine Administration
Conclusion The joint response of science and medicine to develop safe and effective COVID-19 vaccines has been brisk and productive. Distribution efforts will now be the next step in limiting the breadth of this pandemic. EMS agencies will play a key role in some areas in the administration of vaccinations for their communities. The authors suggest that to better clarify the side effects of the COVID-19 vaccines, EMS systems must maintain a log of the type and incidence of adverse events following vaccine administration, EMS responses to the adverse events, as well as those patients’ outcomes from this manageme...
Source: JEMS Operations - December 16, 2020 Category: Emergency Medicine Authors: JEMS Staff Tags: Coronavirus Exclusives EMS EMT Paramedic Source Type: news

Emergency Considerations in COVID-19 Vaccine Administration
Conclusion The joint response of science and medicine to develop safe and effective COVID-19 vaccines has been brisk and productive. Distribution efforts will now be the next step in limiting the breadth of this pandemic. EMS agencies will play a key role in some areas in the administration of vaccinations for their communities. The authors suggest that to better clarify the side effects of the COVID-19 vaccines, EMS systems must maintain a log of the type and incidence of adverse events following vaccine administration, EMS responses to the adverse events, as well as those patients’ outcomes from this manageme...
Source: JEMS Special Topics - December 16, 2020 Category: Emergency Medicine Authors: JEMS Staff Tags: Coronavirus Exclusives EMS EMT Paramedic Source Type: news

Managing anaphylaxis: guidance for GPs delivering the Covid-19 vaccine, RCGP
This RCGP webinar features three doctors discussing the management of anaphylaxis in the context of the COVID-19 vaccine. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - December 16, 2020 Category: Consumer Health News Source Type: news

How Long For Masks After Covid Vaccine? Dr. Mallika Marshall Answers Your Questions
cbsoptanon.onScriptsReady(function(cmp){cmp.ot.targetingAllowed(function(a){if(a) AnvatoPlayer("p5").init({"mcp":"cbs","width":"100%","height":"100%","video":"5087608","autoplay":false,"titleVisible":false,"accessKey":"EZqvRyKE7qmqDflDPXIw6U7kKZEA0Vx7","accessControl":{"preview":false},"pInstance":"p5","plugins":{"heartbeat":{"account":"cbslocal-global-unified","publisherId":"cbslocal","jobId...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - December 15, 2020 Category: Consumer Health News Authors: Health – CBS Boston Tags: Boston News Covid-19 Boston, MA Health Healthcare Status Healthwatch Syndicated Local Coronavirus Coronavirus Vaccine Source Type: news

Extraction with an electric motor-driven handpiece may still cause subcutaneous emphysema - A case report
This article reported a case of SE around the paraorbital and submandibular regions through extractions of teeth 28 and 38. This 20-year-old man came to the emergency room at night with the major complaint of pain and discomfort during swallowing. Sudden swelling at his left face during extractions of teeth 28 and 38 three hours ago was mentioned. The original surgeon who performed the odontectomy was aware of the SE after removing the surgical drape and specific post-operation instructions were given as follows: immediate hospital care may be needed if the patient encountered difficulties in swallowing or any worsen compl...
Source: Dental Technology Blog - December 14, 2020 Category: Dentistry Source Type: news

C.D.C. Panel Recommends Pfizer Vaccine for Patients as Young as 16
The advisory panel of experts endorsed the vaccine and will soon issue specific guidance for pregnant and lactating women and for people who have had severe allergic reactions to other shots. (Source: NYT Health)
Source: NYT Health - December 12, 2020 Category: Consumer Health News Authors: Jan Hoffman Tags: your-feed-science Vaccination and Immunization Coronavirus (2019-nCoV) Breastfeeding Anaphylactic Shock Centers for Disease Control and Prevention Pfizer Inc your-feed-healthcare Source Type: news

Pfizer ’s COVID vaccine and allergies: How concerned should you be?
The British drug regulators issued a warning after two health care workers, both with such a history, had a serious reaction, anaphylaxis, after receiving the vaccine on the first day it became available in Britain. (Source: The Economic Times)
Source: The Economic Times - December 12, 2020 Category: Consumer Health News Source Type: news

Pfizer's Covid Vaccine and Allergies: How Concerned Should You Be?
British health officials recommended that people with severe allergy reactions not be given the vaccine. Such reactions to vaccines are rare, even in people who have allergies to food or bee stings. (Source: NYT Health)
Source: NYT Health - December 11, 2020 Category: Consumer Health News Authors: Denise Grady Tags: Coronavirus (2019-nCoV) Vaccination and Immunization Coronavirus Risks and Safety Concerns Clinical Trials Anaphylactic Shock Allergies Food and Drug Administration Pfizer Inc your-feed-healthcare Source Type: news

Confirmation of guidance to vaccination centres on managing allergic reactions following COVID-19 vaccination with the Pfizer/BioNTech vaccine, MHRA (published 9th December 2020)
MHRA has advised that any person with a history of anaphylaxis to a vaccine, medicine or food should not receive the Pfizer/BioNTech vaccine; and a second dose should not be given to anyone who has experienced anaphylaxis following administration of the first dose of this vaccine. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - December 11, 2020 Category: Consumer Health News Source Type: news